+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Female Contraceptive Market Research Report by Contraceptive Drug, Contraceptive Devices, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 228 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4904506
UP TO OFF until Dec 31st 2022
The Global Female Contraceptive Market size was estimated at USD 8,266.40 million in 2021, USD 8,773.28 million in 2022, and is projected to grow at a CAGR 6.30% to reach USD 11,932.56 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Female Contraceptive to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Contraceptive Drug, the market was studied across Contraceptive Injections, Contraceptive Pills, Spermicides, and Topical Contraceptives. The Contraceptive Pills is further studied across Hormonal Pills and Non-hormonal Pills.
  • Based on Contraceptive Devices, the market was studied across Contraceptive Patches, Contraceptive Sponges, Diaphragms and Caps, Female Condoms, Intra Uterine Contraceptive Devices (IUCDs), Sub-dermal Contraceptive Implants, and Vaginal Rings.
  • Based on Distribution Channel, the market was studied across Clinic, Hospital Pharmacy, Independent Pharmacy, and Online Platform.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Female Contraceptive market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Female Contraceptive Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Female Contraceptive Market, including Allergan plc, Bayer AG, Cipla Limited, HLL Lifecare Limited, Johnson & Johnson, Mankind Pharma, Merck Sharp & Dohme Corp, Mithra Pharmaceuticals S.A., Pfizer Inc., and Reckitt Benckiser Group plc.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Female Contraceptive Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Female Contraceptive Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Female Contraceptive Market?
4. What is the competitive strategic window for opportunities in the Global Female Contraceptive Market?
5. What are the technology trends and regulatory frameworks in the Global Female Contraceptive Market?
6. What is the market share of the leading vendors in the Global Female Contraceptive Market?
7. What modes and strategic moves are considered suitable for entering the Global Female Contraceptive Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of unwanted pregnancies and sexually transmitted diseases
5.1.1.2. Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population
5.1.1.3. Multiple types and ease of availability of contraceptives
5.1.2. Restraints
5.1.2.1. Side effects of contraceptive drugs
5.1.3. Opportunities
5.1.3.1. Availability of contraceptives method such as Sino-Implants and novel contraceptive
5.1.3.2. Government and non-government organizations supporting programs to encourage contraception in emerging economies
5.1.4. Challenges
5.1.4.1. Social stigma and misconceptions about different contraceptives
5.2. Cumulative Impact of COVID-19
6. Female Contraceptive Market, by Contraceptive Drug
6.1. Introduction
6.2. Contraceptive Injections
6.3. Contraceptive Pills
6.3.1. Hormonal Pills
6.3.2. Non-hormonal Pills
6.4. Spermicides
6.5. Topical Contraceptives
7. Female Contraceptive Market, by Contraceptive Devices
7.1. Introduction
7.2. Contraceptive Patches
7.3. Contraceptive Sponges
7.4. Diaphragms and Caps
7.5. Female Condoms
7.6. Intra Uterine Contraceptive Devices (IUCDs)
7.7. Sub-dermal Contraceptive Implants
7.8. Vaginal Rings
8. Female Contraceptive Market, by Distribution Channel
8.1. Introduction
8.2. Clinic
8.3. Hospital Pharmacy
8.4. Independent Pharmacy
8.5. Online Platform
9. Americas Female Contraceptive Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Female Contraceptive Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Female Contraceptive Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Allergan plc
13.2. Bayer AG
13.3. Cipla Limited
13.4. HLL Lifecare Limited
13.5. Johnson & Johnson
13.6. Mankind Pharma
13.7. Merck Sharp & Dohme Corp
13.8. Mithra Pharmaceuticals S.A.
13.9. Pfizer Inc.
13.10. Reckitt Benckiser Group plc
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL FEMALE CONTRACEPTIVE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET DYNAMICS
FIGURE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2021 VS 2027 (%)
FIGURE 9. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2027
FIGURE 11. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2021 VS 2027 (%)
FIGURE 24. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2021 VS 2027 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2027
FIGURE 26. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS AND CAPS, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS AND CAPS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES (IUCDS), 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES (IUCDS), BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, 2019-2027 (USD MILLION)
FIGURE 37. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 38. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, 2019-2027 (USD MILLION)
FIGURE 39. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 40. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 41. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 43. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, 2019-2027 (USD MILLION)
FIGURE 44. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 45. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2019-2027 (USD MILLION)
FIGURE 46. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 47. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, 2019-2027 (USD MILLION)
FIGURE 48. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 49. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, 2019-2027 (USD MILLION)
FIGURE 50. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 51. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 53. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2027
FIGURE 55. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 61. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2027
FIGURE 63. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 65. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 66. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2027
FIGURE 67. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 80. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 81. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2027
FIGURE 82. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 88. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 89. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 90. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 91. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 92. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 93. GLOBAL FEMALE CONTRACEPTIVE MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 94. GLOBAL FEMALE CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 95. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL FEMALE CONTRACEPTIVE MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL FEMALE CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, BY REGION, 2019-2027 (USD MILLION)
TABLE 38. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, BY STATE, 2019-2027 (USD MILLION)
TABLE 40. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, BY REGION, 2019-2027 (USD MILLION)
TABLE 43. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, BY STATE, 2019-2027 (USD MILLION)
TABLE 45. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS AND CAPS, BY REGION, 2019-2027 (USD MILLION)
TABLE 48. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS AND CAPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS AND CAPS, BY STATE, 2019-2027 (USD MILLION)
TABLE 50. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS AND CAPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS AND CAPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, BY REGION, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 55. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES (IUCDS), BY REGION, 2019-2027 (USD MILLION)
TABLE 58. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES (IUCDS), BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES (IUCDS), BY STATE, 2019-2027 (USD MILLION)
TABLE 60. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES (IUCDS), BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES (IUCDS), BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 63. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 65. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2019-2027 (USD MILLION)
TABLE 68. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY STATE, 2019-2027 (USD MILLION)
TABLE 70. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 73. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, BY REGION, 2019-2027 (USD MILLION)
TABLE 74. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, BY STATE, 2019-2027 (USD MILLION)
TABLE 76. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 79. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 81. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 84. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 85. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 86. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY REGION, 2019-2027 (USD MILLION)
TABLE 89. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 90. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY STATE, 2019-2027 (USD MILLION)
TABLE 91. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 93. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 95. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 96. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 97. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 98. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 100. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 101. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 102. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 103. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 104. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 105. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 106. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 107. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 108. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 109. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 110. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 111. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 112. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 113. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 114. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 115. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 116. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 117. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 118. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 119. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 120. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 121. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 122. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 123. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 124. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 125. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 126. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 127. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 128. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 129. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 130. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 131. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 132. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 133. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 134. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 135. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 136. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 137. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 138. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 139. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 140. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 141. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 142. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 143. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 144. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 145. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 146. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 147. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 148. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 149. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 150. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 151. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 152. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 153. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 154. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 155. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 156. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 157. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 158. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 159. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 160. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 161. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 162. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 163. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 164. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 165. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 166. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 167. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 173. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 174. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 175. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 176. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 177. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 178. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 179. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 180. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 181. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 182. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 183. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 184. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 185. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 186. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 187. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 188. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 189. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 190. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 191. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 192. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 193. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 194. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 195. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 196. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 197. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 198. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 199. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 200. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 201. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 202. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 203. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 204. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 205. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 206. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 207. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 208. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 213. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 214. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2019-2027 (USD MILLION)
TABLE 215. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2019-2027 (USD MILLION)
TABLE 216. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 217. GLOBAL FEMALE CONTRACEPTIVE MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 218. GLOBAL FEMALE CONTRACEPTIVE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 219. GLOBAL FEMALE CONTRACEPTIVE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 220. GLOBAL FEMALE CONTRACEPTIVE MARKET RANKING
TABLE 221. GLOBAL FEMALE CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2021
TABLE 222. GLOBAL FEMALE CONTRACEPTIVE MARKET MERGER & ACQUISITION
TABLE 223. GLOBAL FEMALE CONTRACEPTIVE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 224. GLOBAL FEMALE CONTRACEPTIVE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 225. GLOBAL FEMALE CONTRACEPTIVE MARKET INVESTMENT & FUNDING
TABLE 226. GLOBAL FEMALE CONTRACEPTIVE MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 227. GLOBAL FEMALE CONTRACEPTIVE MARKET: LICENSE & PRICING

Companies Mentioned

  • Allergan plc
  • Bayer AG
  • Cipla Limited
  • HLL Lifecare Limited
  • Johnson & Johnson
  • Mankind Pharma
  • Merck Sharp & Dohme Corp
  • Mithra Pharmaceuticals S.A.
  • Pfizer Inc.
  • Reckitt Benckiser Group plc

Methodology

Loading
LOADING...